The Obama administration says altering human genes for medical purposes is a “line that shouldn’t be crossed” right now.

It is important to examine the ethical implications of using new technologies to altar the human genome, John Holdren, director of the White House Office of Science and Technology Policy, wrote Tuesday morning on the White House blog.